This article first appeared on GuruFocus .
-
Consolidated Revenue (9 months ended Dec 31, 2025):$2.21 billion compared to $2.25 billion in the prior year period.
-
Operating Income (9 months ended Dec 31, 2025):$183.4 million versus $190 million in the prior year period.
-
Net Income (9 months ended Dec 31, 2025):$75.9 million versus $85.7 million in the prior year period.
-
Tobacco Operations Revenue (9 months ended Dec 31, 2025):$1.94 billion compared to $2 billion in the prior year period.
-
Tobacco Operations Segment Operating Income (9 months ended Dec 31, 2025):$185 million versus $194.4 million in the prior year period.
-
Ingredients Operations Revenue (9 months ended Dec 31, 2025):$265.2 million compared to $249 million in the prior year period.
-
Ingredients Operations Segment Operating Income (9 months ended Dec 31, 2025):$1.4 million compared to $7.9 million in the prior year period.
-
Consolidated Revenue (Q3 FY 2026):$861.3 million compared to $937.2 million in the same quarter of last year.
-
Operating Income (Q3 FY 2026):$82 million versus $104.1 million in the third quarter of last fiscal year.
-
Net Income (Q3 FY 2026):$33.2 million versus $59.6 million in the third quarter of last fiscal year.
-
Tobacco Operations Revenue (Q3 FY 2026):$779.9 million compared to $853.9 million in the same quarter of last year.
-
Tobacco Operations Segment Operating Income (Q3 FY 2026):$84 million versus $102.6 million in the third quarter of last fiscal year.
-
Ingredients Operations Revenue (Q3 FY 2026):$81.3 million compared to $83.3 million in the third quarter last year.
-
Ingredients Operations Segment Operating Loss (Q3 FY 2026):$0.1 million compared to segment operating income of $3.7 million in the third quarter of last fiscal year.
-
Net Debt (as of Dec 31, 2025):$995 million compared to $945 million at the same point last year.
-
Liquidity Availability (as of Dec 31, 2025):$917 million.
Release Date: February 09, 2026
For the complete transcript of the earnings call, please refer to the full earnings call transcript .
Positive Points
-
Universal Corp ( NYSE:UVV ) reported solid performance in the tobacco operations segment, maintaining firm customer demand despite transitioning into an oversupply environment.
-
The company successfully refinanced and upsized its corporate credit facility by $250 million, significantly expanding liquidity and improving financial flexibility.
-
Universal Corp ( NYSE:UVV ) announced the appointment of a new CFO, Steven S. Diel, bringing strong financial and strategic expertise to the company.
-
The company has made significant progress in advancing its sustainability priorities, including increasing renewable electricity consumption nearly sixfold year-over-year.
-
Universal Corp ( NYSE:UVV ) continues to leverage its diverse global footprint and long-standing customer relationships to optimize results in the tobacco market.
Negative Points
-
Consolidated revenue for the third quarter of fiscal year 2026 decreased to $861.3 million from $937.2 million in the same quarter last year.
-
Operating income for the third quarter fell to $82 million from $104.1 million in the previous year, indicating a decline in profitability.
-
The Ingredients Operations segment faced higher fixed costs from significant investments, compressing margins and impacting overall segment results.
-
Market headwinds, including softness in the consumer packaged goods sector and pronounced tariff impacts, weighed on the business.
-
Net income for the third quarter dropped to $33.2 million from $59.6 million in the same quarter last year, reflecting decreased earnings.
Q & A Highlights
Q: How are tariffs and market weakness affecting both traditional and newer solutions-based offerings in the Ingredients segment? A: Preston Wigner, CEO, explained that market headwinds, including consumer packaged goods sector weakness and inflationary pressures, are compressing margins and tightening demand. Tariffs have increased costs, impacting product pricing and sales. The company is focused on scaling the business to absorb fixed costs and increase sales, with a 7% year-to-date sales increase despite challenges.
Q: Can you provide insights into the tobacco segment's performance and expectations for fiscal '26 margins? A: Preston Wigner noted that while fiscal 2025 was extraordinary, the current year remains strong. The tobacco segment's performance is solid, with large crops and firm demand. However, pricing is slightly down, and write-downs in certain tobaccos have impacted results. The company is working to ship higher-margin tobacco in the fourth quarter, with margins dependent on shipment timing and product mix.
Q: What is the status of customer inventory levels and duration positions in the tobacco segment? A: Preston Wigner stated that customer inventory levels vary, with some restoring durations and others maintaining lower levels. The estimated unsold flue-cured and Burley stock was about 102 million kilos as of December 31, 2025, similar to the previous quarter.
Q: What were the biggest surprises in the Ingredients segment's Q3 results compared to Q2? A: Preston Wigner highlighted that the prolonged market headwinds impacting customers were more significant than expected. Despite challenges, the company remains focused on converting customer interest into sales and navigating cyclical market conditions.
Q: Can you provide an update on cross-selling opportunities and investments in commercial sales? A: Preston Wigner emphasized efforts to build an active product development pipeline and engage commercial sales teams with existing and new customers. Cross-selling within the Universal Ingredients platform is a key focus, contributing to increased sales and product offerings.
For the complete transcript of the earnings call, please refer to the full earnings call transcript .
